检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:韩鹏[1] 李力仙[1] HAN Peng, LI Lixian(Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, Chin)
机构地区:[1]哈尔滨医科大学附属第一临床医院神经外科,哈尔滨150001
出 处:《临床与病理杂志》2018年第2期424-428,共5页Journal of Clinical and Pathological Research
摘 要:脑水肿是脑出血后必然出现的病理生理过程,是脑出血后最严重的并发症,会导致出血后脑组织的二次脑损伤。同时,因其发生时细胞外液体增加,致使颅内压升高,进而使得神经功能受损,造成严重的不良后果。脑水肿的发病机制较多且复杂,只有根据发病机制及致病因素对症治疗、消除颅内高压才是治疗水肿的可行方法,因此迫切需要开发新的、有效的抗水肿药物。Cerebral edema is an inevitable pathophysiological process after intracerebral hemorrhage. It is the most serious complication after intracerebral hemorrhage and leads to second brain injury in brain tissue after hemorrhage. Cerebral edema has serious adverse consequences. Increased extracellular fluid leads to increased intracranial pressure, resulting in impaired neurological function. The pathogenesis of cerebral edema is more and more complex; only based on pathogenesis and risk factors for symptomatic treatment and elimination of intracranial hypertension are feasible methods to treat edema. It is necessary to develop new and effective anti-edema drugs.
分 类 号:R743.34[医药卫生—神经病学与精神病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.176